May 05, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
DESTIN, Fla. — Combination therapy with multiple biologics may be on the horizon for patients with psoriatic arthritis, according to a presenter at the Congress of Clinical Rheumatology East.“We are doing way better with psoriatic arthritis,” said Arthur Kavanaugh, MD, a rheumatologist and professor of medicine at the University of California San Diego. “We really want
May 05, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

For decades, biologics have been the gold standard for psoriasis treatment. Now, the psoriasis therapeutic landscape is…

DENVER — Adults with active psoriatic arthritis and obesity had improvements in disease activity, physical function, weight loss…

The novel interleukin-17AA targeted molecule izokibep showed ACR50 response rates of more than 50% in psoriatic arthritis at 52…

DESTIN, Fla. — Most patients with systemic sclerosis require treatment with multiple modes of action, according to a presenter at…

Psoriatic arthritis biologics square off, novel molecules and mechanisms, and old drugs made new

The emergence of biologic therapies ushered in an era of unprecedented positive outcomes for patients with rheumatic and…